This site uses cookies in order to function as expected. By continuing, you are agreeing to our cookie policy.
Agree and close

« April 2020 »
Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Event Use of Genetic resources - the impact of a new regulatory framework on your R&D activities

workable system for access to genetic resources is crucial for the future of our life sciences and biotech companies. A new international legal framework has been set up, known as the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits arising from their Uitilisation. Since the adoption of the Nagoya Protocol, the matter of so called Access and Benefit Sharing (ABS) has grown in importance. Regional and national implementing laws are currently under discussion. On October 2015, the EU Regulation 511/2014 of 16 April 2014 on compliance measures on ABS will come into full force. Work on additional (sector specific) guidance is ongoing. The federal and regional authorities are currently also establishing the Belgian legal framework on ABS.
An ideal momentum to learn about this new regulatory framework, exchange views with others, chech wether you are compliant with these new rules and to take part in the ongoing discussions.

Download as iCalendar

Period 02/10/2015
Event location Technopolis Technologiƫlaan, 2800 Mechelen
Host Essencia
Event URL http://www.essenscia.be/en/calendar/event/259
Contact person Cathy PLASMAN
cplasman@essenscia.be

Program

13.00   Registration
13.30   Welcome  
            Cathy Plasman, essenscia/bio.be

Use of genetic resources: context and history of a new legal framework
13.40   The brave new world of access and benefit sharing    
            Dominic Muyldermans, ABS-int
14.00   The EU context
            Alicia Koslowski - Leo Maier, EC DG ENV
14.20   Situation of ABS policy in Belgium
            Salima Kempeneer, Focal Point, Fed Government

Use of genetic resources: obligations on access and benefit sharing & compliance
14.40   Impact on IPR and Technology Transfer
            Emil Pot, founder ActoGeniX1
15.00   Facilitating access to microbial material: the BCCM proactive policy
            Philippe Desmeth, BELSPO 
15.20   Impact on the plant breeding sector
            Frank Michiels, Bayer CropScience NV
15.40   Vaccines Case Study
            Cody Taylor, GSK
16.00   The algue case
            Tom Domen, Ecover
16.20   Panel –  Q&A
           
Regional Government representatives and previous speakers
            Moderated by  : Patrick Rudelsheim & Dominic Muyldermans, ABS-int
17.00   Elke Sleurs, Secretary of State for Science Policy
17.15   Drink


Free registration
No show fee 40 €

logo CBD logo NFP Belgium logo RBINS